Literature DB >> 27424062

Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.

Ricardo E Carrión1, Docia Demmin2, Andrea M Auther3, Danielle McLaughlin2, Ruth Olsen2, Todd Lencz4, Christoph U Correll4, Barbara A Cornblatt4.   

Abstract

Research in individuals at clinical high-risk (CHR) for psychosis has focused on subjects with no more than 12 months of present or worsened attenuated positive symptoms. However, the impact of long duration attenuated positive and/or negative prodromal symptoms on outcomes is unclear. Seventy-six CHR subjects with attenuated positive symptoms and at least moderate severity level negative symptoms rated on the Scale of Prodromal Symptoms (SOPS) were prospectively followed for a mean of 3.0 ± 1.6 years. Social and Role functioning was assessed with the Global Functioning: Social and Role scales. Correlations between attenuated positive and negative symptom duration and severity and conversion to psychosis and functional outcomes were analyzed. The average onset of SOPS rated negative symptoms (M = 53.24 months, SD = 48.90, median = 37.27) was approximately twelve months prior to the emergence of attenuated positive symptom (M = 40.15 months, SD = 40.33, median = 24.77, P < 0.05). More severe positive symptoms (P = 0.004), but not longer duration of positive (P = 0.412) or negative (P = 0.754) symptoms, predicted conversion to psychosis. Neither positive symptom duration (P = 0.181) nor severity (P = 0.469) predicted role or social functioning at study endpoint. Conversely, longer negative symptom duration predicted poor social functioning (P = 0.004). Overall, our findings suggest that the severity of attenuated positive symptoms at baseline may be more important than symptom duration for determining individuals at increased risk of developing psychosis. In contrast, long-standing negative symptoms may be associated with persistent social difficulties and therefore have an important position in the treatment of disability.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attenuated positive symptoms; Clinical high risk; Early intervention; Functional outcome; Negative symptoms; Psychosis

Mesh:

Year:  2016        PMID: 27424062      PMCID: PMC5021595          DOI: 10.1016/j.jpsychires.2016.06.021

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  51 in total

Review 1.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 2.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

3.  Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis.

Authors:  P Fusar-Poli; A Meneghelli; L Valmaggia; P Allen; F Galvan; P McGuire; A Cocchi
Journal:  Br J Psychiatry       Date:  2009-02       Impact factor: 9.319

4.  Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

Authors:  D G Robinson; M G Woerner; J M Alvir; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; R Bilder; R Goldman; J A Lieberman
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

5.  Catamnestic long-term study on the course of life and aging of schizophrenics.

Authors:  L Ciompi
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

Review 6.  Early detection and intervention with schizophrenia: rationale.

Authors:  T H McGlashan; J O Johannessen
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

Review 7.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

8.  Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt
Journal:  Am J Psychiatry       Date:  2011-05-02       Impact factor: 18.112

9.  Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms.

Authors:  Feea R Leifker; Christopher R Bowie; Philip D Harvey
Journal:  Schizophr Res       Date:  2009-09-22       Impact factor: 4.939

10.  Premorbid and onset features of first-episode schizophrenia.

Authors:  G L Haas; J A Sweeney
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

View more
  20 in total

Review 1.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

2.  Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.

Authors:  TianHong Zhang; LiHua Xu; YingYing Tang; HuiRu Cui; XiaoChen Tang; YanYan Wei; Yan Wang; Qiang Hu; ZhenYing Qian; XiaoHua Liu; ChunBo Li; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-25       Impact factor: 5.270

3.  Predictors of social functioning in patients with higher and lower levels of reduced emotional experience: Social cognition, social competence, and symptom severity.

Authors:  Philip D Harvey; Elizabeth Deckler; Fredrik Jarskog; David L Penn; Amy E Pinkham
Journal:  Schizophr Res       Date:  2018-11-13       Impact factor: 4.939

4.  Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

Authors:  Cynthia Z Burton; Ivy F Tso; Ricardo E Carrión; Tara Niendam; Steven Adelsheim; Andrea M Auther; Barbara A Cornblatt; Cameron S Carter; Ryan Melton; Tamara G Sale; Stephan F Taylor; William R McFarlane
Journal:  Schizophr Res       Date:  2019-08-06       Impact factor: 4.939

5.  Brain-based ranking of cognitive domains to predict schizophrenia.

Authors:  Teresa M Karrer; Danielle S Bassett; Birgit Derntl; Oliver Gruber; André Aleman; Renaud Jardri; Angela R Laird; Peter T Fox; Simon B Eickhoff; Olivier Grisel; Gaël Varoquaux; Bertrand Thirion; Danilo Bzdok
Journal:  Hum Brain Mapp       Date:  2019-07-16       Impact factor: 5.038

6.  Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis.

Authors:  Irina S Boksha; Maria A Omel'chenko; Olga K Savushkina; Tatyana A Prokhorova; Elena B Tereshkina; Elena A Vorobyeva; Gulnur Sh Burbaeva
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-15       Impact factor: 5.270

7.  Altered selection during language processing in individuals at high risk for psychosis.

Authors:  Teresa Vargas; Hannah Snyder; Marie Banich; Rae Newberry; Stewart A Shankman; Gregory P Strauss; Vijay Anand Mittal
Journal:  Schizophr Res       Date:  2018-06-20       Impact factor: 4.939

8.  Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Authors:  D J Devoe; L Lu; T D Cannon; K S Cadenhead; B A Cornblatt; T H McGlashan; D O Perkins; L J Seidman; M T Tsuang; S W Woods; E F Walker; D H Mathalon; C E Bearden; J Addington
Journal:  Schizophr Res       Date:  2020-04-30       Impact factor: 4.939

9.  Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.

Authors:  Martina Maria Mensi; Silvia Molteni; Melanie Iorio; Eleonora Filosi; Elena Ballante; Umberto Balottin; Paolo Fusar-Poli; Renato Borgatti
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

10.  Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Authors:  Daniel J Hauke; André Schmidt; Erich Studerus; Christina Andreou; Anita Riecher-Rössler; Joaquim Radua; Joseph Kambeitz; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Theresa Lichtenstein; Rachele Sanfelici; Nora Penzel; Shalaila S Haas; Linda A Antonucci; Paris Alexandros Lalousis; Katharine Chisholm; Frauke Schultze-Lutter; Stephan Ruhrmann; Jarmo Hietala; Paolo Brambilla; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Pantelis; Marlene Rosen; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Stefan Borgwardt
Journal:  Transl Psychiatry       Date:  2021-05-24       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.